SARS-CoV-2-IN-24

SARS-CoV-2-IN-24

• UNSPSC Description: SARS-CoV-2-IN-24 (compound 7) is a potent papain-like protease (PLpro) inhibitor. SARS-CoV-2-IN-24 induces conformational changes in SARS-COV-2 papain-like protease, inhibiting SARS-CoV-2 replication. SARS-CoV-2-IN-24 can be used for SARS-CoV-2 research[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-24.html
• Solubility: 10 mM in DMSO
• Smiles: COC(CCC(NNC(CCC1=CC=C(C=C1C(N[C@@H](C2=C3C=CC=CC3=CC=C2)C)=O)N)=O)=O)=O
• Molecular Weight: 490.55
• References & Citations: [1]Ferreira GM, et, al. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Sci Rep. 2022 Jul 8;12(1):11585.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported